Journals / Journal of Mood Disorders / 2017 / Cilt: 7 - Sayı: 1

Bipolar disorder and inflammation

İki uçlu bozukluk ve inflamasyon

Pages
54–64
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Acute phase proteins, which are produced andinduced by the effect of cytokines, are also reviewed.Finally, we discuss the role of anti-inflammatory agents intreatment of bipolar disorder and offer suggestions aboutfuture researches.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:There is growing number of researches showing evidenceabout the role of inflammation in pathophysiology ofbipolar disorder.
📊
Key Findings & Data:Besides inflammation in central nervoussystem, systemic inflammation is also thought to beassociated with the acute and euthymic episodes andclinical outcome of illness.
💡
Conclusion & Impact:Acute phase proteins, which are produced andinduced by the effect of cytokines, are also reviewed.Finally, we discuss the role of anti-inflammatory agents intreatment of bipolar disorder and offer suggestions aboutfuture researches.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

There is growing number of researches showing evidenceabout the role of inflammation in pathophysiology ofbipolar disorder. Besides inflammation in central nervoussystem, systemic inflammation is also thought to beassociated with the acute and euthymic episodes andclinical outcome of illness. In this reviewö we firstlyfocus on the quantitative and structural changes inimmune cells and their relationship with the illnessepisodes. Also cytokines, which have an important role ininflammation and are measurable in systemic circulation,are summarized. In addition to changes of inflammatorymarkers in different episodes of bipolar disorder, wemention the effect of bipolar disorder treatments on thesemarkers. Acute phase proteins, which are produced andinduced by the effect of cytokines, are also reviewed.Finally, we discuss the role of anti-inflammatory agents intreatment of bipolar disorder and offer suggestions aboutfuture researches.

Özet

İki uçlu bozukluğun patofizyolojisinde inflamasyonun darol oynadığına dair çalışmalar ve bulgular giderek artmaktadır.Santral inflamasyonun yanı sıra sistemik immünyanıtın da hastalığın akut ve ötimik dönemleriyle veprognozla ilişkili olduğu düşünülmektedir. Bu derlemedeilk olarak immün sistem hücrelerinin sayısal ve yapısaldurumu gözden geçirilerek hastalığın dönemleriyle ilişkisinebakılacaktır. İnflamatuar yanıtta etkin rol oynayan vesistemik dolaşımda da ölçülebilen sitokinler incelenecektir.İnflamatuar belirteçlerin iki uçlu bozukluğun dönemleriyleilişkisinin yanı sıra iki uçlu bozukluk tedavileriyle değişimleride gözden geçirilecek ve üretimi sitokinler tarafındanindüklenen akut faz proteinlerinden de sözedilecektir.Yazımızın son kısmında iki uçlu bozuklukta anti-inflamatuarilaçların kullanımıyla ilgili çalışmalara değinilmiş ve gelecekçalışmalarla ilgili öneriler sunulmuştur.

🔖

Cite This Article

GENÇ, A., KARAMUSTAFALIOĞLU, N., KALELİOĞLU, T. (2022). Bipolar disorder and inflammation. Journal of Mood Disorders, Cilt: 7 - Sayı: 1, 54–64. https://ajindex.com/articles/564520

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab. 2013
  2. 33(1):13-21. [CrossRef] 2. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015
  3. 523(7560):337-41. [CrossRef] 3. Chen G, Reichlin S. Clearance of [125I]-tumor necrosis factoralpha from the brain into the blood after intracerebroventricular injection in rats. Neuroimmunomodulation. 1998
  4. 5(5):261-9. [CrossRef] 4. Gimsa U, Mitchison NA, Brunner-Weinzierl MC. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation. Mediators Inflamm. 2013
  5. 320519. [CrossRef] 5. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol. 2012
  6. 92(5):959-75. [CrossRef] 6. Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010
  7. 12(6):638-46. [CrossRef] 7. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010
  8. 15(4):384-92. [CrossRef] 8. Söderlund J, Olsson SK, Samuelsson M, Walther-Jallow L, Johansson C, Erhardt S, et al. Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder. J Psychiatry Neurosci. 2011
  9. 36(2):114-8. [CrossRef] 9. Acharjee S, Branton WG, Vivithanaporn P, Maingat F, Paul AM, Dickie P, et al. HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain Behav Immun. 2014
  10. [CrossRef] 10. Kalelioglu T, Akkus M, Karamustafalioglu N, Genc A, Genc ES, Cansiz A, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder. Psychiatry Res. 2015
  11. 228(3):925-7. [CrossRef] 11. Çakır U, Tuman TC, Yıldırım O. Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: a preliminary study. Psychiatr Danub. 2015
  12. 27(2):180-4. 12. Kalelioglu T, Tasdemir A, Genc A, Genc ES, Ozver I, Yesilbas D, et al. Complete blood count, kidney, liver function tests and other biochemical parameters in patients whom were under lithium monotherapy treatment. Journal o